Seroprevalence of Enterovirus D68 infection among humans: A systematic review and meta-analysis.
Journal
Intervirology
ISSN: 1423-0100
Titre abrégé: Intervirology
Pays: Switzerland
ID NLM: 0364265
Informations de publication
Date de publication:
04 Oct 2023
04 Oct 2023
Historique:
received:
12
03
2022
accepted:
26
06
2023
medline:
5
10
2023
pubmed:
5
10
2023
entrez:
4
10
2023
Statut:
aheadofprint
Résumé
Human enterovirus D68 (EV-D68), which belongs to enteroviruses of the small RNA family, is a type of enterovirus that can cause acute respiratory tract infection and central nervous system diseases. This study systematically analysed and summarized EV-D68 antibody studies in databases and identified the seropositivity rates of different regions, ages, and sexes. Meta-analysis was performed using STATA 16.0 software. I2 and Q tests were used to analyse the heterogeneity of the included studies. Meta-regression analysis was performed for different groups, and Egger's linear regression analysis was used to evaluate publication bias. The results of multiple studies indicated that the serological prevalence range of EV-D68 antibody was 17.78%-96.69%. The results of the meta-analysis showed that the seropositivity rate of EV-D68 antibody was 76% (95% CI: 67%-84%), among which that of the Chinese population was 74% (95% CI: 61%-86%) and that of other countries was 79% (95% CI: 65%-91%). At the same time, a subgroup analysis was conducted. The seroprevalence of EV-D68 antibody was related to age but not sex or region. The seropositivity rate was lower in the below 5 years age group; however, it gradually increased with age. The results of this study showed that EV-D68 infection was widespread in the population, and the current clinical infection situation could not reflect the actual epidemic situation of the virus, among which children under 5 years old were vulnerable to infection, which should be given greater attention for epidemic prevention and control.
Identifiants
pubmed: 37793363
pii: 000531853
doi: 10.1159/000531853
pmc: PMC10614446
doi:
Types de publication
Meta-Analysis
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
The Author(s). Published by S. Karger AG, Basel.
Références
J Microbiol Immunol Infect. 2019 Dec;52(6):858-864
pubmed: 31164279
Emerg Infect Dis. 2018 Nov;24(11):2115-2117
pubmed: 30334718
J Virol. 2015 Dec 09;90(4):1997-2007
pubmed: 26656685
Emerg Microbes Infect. 2018 Jun 6;7(1):99
pubmed: 29872035
J Biol Chem. 2021 Jan-Jun;296:100317
pubmed: 33484714
J Clin Virol. 2015 Aug;69:117-21
pubmed: 26209392
Euro Surveill. 2020 Jan;25(2):
pubmed: 31964463
Clin Infect Dis. 2018 Feb 10;66(5):653-664
pubmed: 29028962
N Engl J Med. 2022 May 26;386(21):2059-2060
pubmed: 35613028
Emerg Infect Dis. 2015 May;21(5):837-41
pubmed: 25898320
J Med Virol. 2022 Jun;94(6):2607-2612
pubmed: 34617599
Pediatr Infect Dis J. 2017 Mar;36(3):290-295
pubmed: 28187115
PLoS One. 2015 Nov 23;10(11):e0142841
pubmed: 26599365
AJNR Am J Neuroradiol. 2015 Feb;36(2):245-50
pubmed: 25414005
Semin Respir Crit Care Med. 2016 Aug;37(4):578-85
pubmed: 27486738
PLoS Negl Trop Dis. 2022 Feb 8;16(2):e0010073
pubmed: 35134062
Antiviral Res. 2018 Nov;159:63-67
pubmed: 30261226
J Infect. 2018 Jun;76(6):563-569
pubmed: 29428227
Jpn J Infect Dis. 2020 Jan 23;73(1):55-57
pubmed: 31474700
Front Neurol. 2020 May 22;11:360
pubmed: 32528396
Lancet Microbe. 2022 Feb;3(2):e83-e85
pubmed: 35036969
J Pediatric Infect Dis Soc. 2018 Dec 26;7(suppl_2):S49-S53
pubmed: 30590621
Euro Surveill. 2014 Nov 06;19(44):
pubmed: 25394254
Euro Surveill. 2015 Mar 12;20(10):21062
pubmed: 25788251
Emerg Infect Dis. 2019 Jun;25(6):1200-1203
pubmed: 30855226
Euro Surveill. 2019 Aug;24(35):
pubmed: 31481149
J Med Virol. 2021 Jun;93(6):3524-3531
pubmed: 32492201
Viruses. 2019 Sep 04;11(9):
pubmed: 31487952
Influenza Other Respir Viruses. 2017 May;11(3):211-219
pubmed: 28122175
Arch Pathol Lab Med. 2011 Jun;135(6):793-6
pubmed: 21631275
PLoS One. 2020 Mar 10;15(3):e0230180
pubmed: 32155216
Emerg Infect Dis. 2019 Mar;25(3):585-588
pubmed: 30789123
Pediatr Infect Dis J. 2018 May;37(5):394-400
pubmed: 29189674
Emerg Microbes Infect. 2017 May 10;6(5):e32
pubmed: 28487560
J Clin Virol. 2015 Jul;68:94-6
pubmed: 26071345
Arch Virol. 2023 Jan 7;168(2):37
pubmed: 36609748
Lancet Infect Dis. 2016 May;16(5):e64-e75
pubmed: 26929196
Swiss Med Wkly. 2023 Feb 08;153:40045
pubmed: 36787499
Pediatr Pulmonol. 2017 Jun;52(6):827-832
pubmed: 28135044
J Epidemiol Community Health. 2013 Nov 1;67(11):974-8
pubmed: 23963506